These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 15041479)

  • 21. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
    Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose phosphodiesterase inhibition improves responsiveness to inhaled nitric oxide in isolated lungs from endotoxemic rats.
    Klein A; Zils U; Bopp C; Gries A; Martin E; Gust R
    J Surg Res; 2007 Apr; 138(2):224-30. PubMed ID: 17275845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cyclic GMP-specific phosphodiesterase inhibitor, sildenafil, stimulates human sperm motility and capacitation but not acrosome reaction.
    Lefièvre L; De Lamirande E; Gagnon C
    J Androl; 2000; 21(6):929-37. PubMed ID: 11105920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
    Takimoto E; Champion HC; Li M; Belardi D; Ren S; Rodriguez ER; Bedja D; Gabrielson KL; Wang Y; Kass DA
    Nat Med; 2005 Feb; 11(2):214-22. PubMed ID: 15665834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged induction of neuronal NOS expression and activity following cortical spreading depression (SD): implications for SD- and NO-mediated neuroprotection.
    Shen PJ; Gundlach AL
    Exp Neurol; 1999 Dec; 160(2):317-32. PubMed ID: 10619550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
    Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH
    Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of cGMP in sildenafil-induced activation of endothelial Ca2+-activated K+ channels.
    Luedders DW; Muenz BM; Li F; Rueckleben S; Tillmanns H; Waldecker B; Wiecha J; Erdogan A; Schaefer CA; Kuhlmann CR
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):365-70. PubMed ID: 16633077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral blood flow changes during cortical spreading depression are not altered by inhibition of nitric oxide synthesis.
    Zhang ZG; Chopp M; Maynard KI; Moskowitz MA
    J Cereb Blood Flow Metab; 1994 Nov; 14(6):939-43. PubMed ID: 7523432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple affinity states of cGMP-specific phosphodiesterase for sildenafil inhibition defined by cGMP-dependent and cGMP-independent mechanisms.
    Rybalkina IG; Tang XB; Rybalkin SD
    Mol Pharmacol; 2010 Apr; 77(4):670-7. PubMed ID: 20086037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NCX-911, a novel nitric oxide-releasing PDE5 inhibitor relaxes rabbit corpus cavernosum in the absence of endogenous nitric oxide.
    Kalsi JS; Kell PD; Cellek S; Ralph DJ
    Int J Impot Res; 2004 Apr; 16(2):195-200. PubMed ID: 14961060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
    Beierwaltes WH
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the nitric oxide donor, DEA/NO on cortical spreading depression.
    Wang M; Obrenovitch TP; Urenjak J
    Neuropharmacology; 2003 Jun; 44(7):949-57. PubMed ID: 12726826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sildenafil inhibits the up-regulation of phosphodiesterase type 5 elicited with nicotine and tumour necrosis factor-alpha in cavernosal vascular smooth muscle cells: mediation by superoxide.
    Hotston MR; Jeremy JY; Bloor J; Koupparis A; Persad R; Shukla N
    BJU Int; 2007 Mar; 99(3):612-8. PubMed ID: 17176295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of human and rabbit vaginal smooth muscle cell cultures: effects of vasoactive agents on intracellular levels of cyclic nucleotides.
    Traish A; Moreland RB; Huang YH; Kim NN; Berman J; Goldstein I
    Mol Cell Biol Res Commun; 1999 Aug; 2(2):131-7. PubMed ID: 10542137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cGMP-binding, cGMP-specific phosphodiesterase (PDE5): intestinal cell expression, regulation and role in fluid secretion.
    Sopory S; Kaur T; Visweswariah SS
    Cell Signal; 2004 Jun; 16(6):681-92. PubMed ID: 15093609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sildenafil induces hyperalgesia via activation of the NO-cGMP pathway in the rat neuropathic pain model.
    Patil CS; Padi SV; Singh VP; Kulkarni SK
    Inflammopharmacology; 2006 Mar; 14(1-2):22-7. PubMed ID: 16835709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil.
    Zhu CB; Hewlett WA; Francis SH; Corbin JD; Blakely RD
    Eur J Pharmacol; 2004 Nov; 504(1-2):1-6. PubMed ID: 15507214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
    Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage.
    Rodríguez-Iturbe B; Ferrebuz A; Vanegas V; Quiroz Y; Espinoza F; Pons H; Vaziri ND
    Kidney Int; 2005 Nov; 68(5):2131-42. PubMed ID: 16221212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.
    Angeli P; Jiménez W; Veggian R; Fasolato S; Volpin R; MacHenzie HS; Craighero R; Libera VD; Sticca A; Arroyo V; Gatta A
    Hepatology; 2000 Feb; 31(2):304-10. PubMed ID: 10655250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.